Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Serpin E1/PAI-1 Antibody, DyLight 680, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP119773FR
Description
Specifically detects Serpin E1/PAI-1 in Human, Mouse, Rat samples, and it is validated for Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blotting
Serpin E1/PAI-1 Polyclonal specifically detects Serpin E1/PAI-1 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.Specifications
Serpin E1/PAI-1 | |
Polyclonal | |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
P05121 | |
SERPINE1 | |
A synthetic peptide made to an internal portion of the human PAI1/Serpine 1 protein (between residues 300-400) [UniProt P05121] | |
Affinity Purified | |
RUO | |
Primary | |
PAI-1 (N315) pAb detects endogenous levels of PAI-1 protein. | |
Store at 4C in the dark. |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
DyLight 680 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
Endothelial plasminogen activator inhibitor, PAI1PAI-1, PAISerpin E1, PLANH1plasminogen activator inhibitor 1, serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogenactivator inhibitor type 1), member 1, serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitortype 1), member 1 | |
Rabbit | |
45 kDa | |
0.1 mL | |
Cancer | |
5054 | |
Human, Mouse, Rat | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction